IP Group Invests £4m in Microbiotica’s £36m Funding Round

IP Group said portfolio company Microbiotica closed a £36m financing, in which IP Group invested £4m. Microbiotica is a clinical-stage biopharmaceutical company developing orally dosed precision microbiome medicines.